Patrice Rioux
CIK: 0001241033
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MNPR
Monopar Therapeutics
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 26, 2026MNPR
Monopar Therapeutics
Exercise(M)Direct1.4K shares at avg. $0.01$6.9 - Aug 26, 2026MNPR
Monopar Therapeutics
Sale(S)Direct1 shares at avg. $111.26$111.26 - Jan 1, 2026MNPR
Monopar Therapeutics
Award(A)DirectStock Option
2K shares- - Jan 1, 2025MNPR
Monopar Therapeutics
Award(A)DirectStock Options
2K shares-
1-4 of 4 transactions
About RIOUX PATRICE
RIOUX PATRICE (SEC CIK 0001241033) files insider reports with the SEC as Monopar Therapeutics (MNPR).
Signal8 holds 3 ownership filings by RIOUX PATRICE, all Form 4s, filed between Jan 2, 2025 and Aug 27, 2026. Those filings report 4 transactions, from Jan 1, 2025 to Aug 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RIOUX PATRICE's filings is in WILMETTE, IL.
Recent filings by RIOUX PATRICE
Other insiders filing for Monopar Therapeutics (MNPR)
- Robinson Chandler, Chief Executive Officer
- STARR CHRISTOPHER M, Director
- Cittadine Andrew, Chief Operating Officer
- Vu Quan Anh, Chief Financial Officer
- Tsuchimoto Kim R, Director
- Anderson Raymond, Director